Literature DB >> 6233770

Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine.

B M Hall, M E Jelbart, S E Dorsch.   

Abstract

DA rats treated with cyclosporine for 2 weeks after being grafted with an RT1-incompatible PVG heart graft did not reject the graft and developed a state of specific unresponsiveness to graft antigens. The cellular mechanisms maintaining this state of unresponsiveness were studied by testing the capacity of lymphocytes from these animals to effect or inhibit graft rejection in irradiated grafted hosts. Whole lymph node and spleen cell populations, and the T cell subpopulation separated from the latter, failed to restore the rejection of PVG hearts in irradiated DA recipients but restored third-party Wistar-Furth (W/F) rejection. Both whole spleen cells and the splenic T cell subpopulation had the capacity to suppress the ability of normal DA lymphocytes to cause graft rejection. Suppression was not dependent upon a state of chimerism in grafted cyclosporine -treated animals, and was not associated with any measurable alterations in the proportion of cytotoxic/suppressor T cells in lymphoid tissues. These studies show that the state of specific unresponsiveness that follows the treatment of heart grafted rats with cyclosporine is dependent, in part, upon active suppression that is induced or mediated by T lymphocytes. Many features of the immune reactivity of cyclosporine -treated grafted rats support the hypothesis that the mechanism of specific suppression in these animals is akin to that of enhancement, rather than to that of transplantation tolerance induced in neonatal rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233770     DOI: 10.1097/00007890-198406000-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

Review 1.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation.

Authors:  R H Hruban; P P Long; E J Perlman; G M Hutchins; W A Baumgartner; K L Baughman; C A Griffin
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

3.  Transplantation tolerance: Clinical potential of regulatory T cells.

Authors:  Yannick D Muller; Jörg D Seebach; Leo H Bühler; Manuel Pascual; Dela Golshayan
Journal:  Self Nonself       Date:  2011-01-01

Review 4.  Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.

Authors:  G N Gaulton; J F Markmann
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

5.  New immunosuppressive drugs: needs in and applications to pediatric transplantation.

Authors:  B D Kahan
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

Review 6.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

7.  Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity.

Authors:  M Braida; J Knop
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

Review 8.  Moving to tolerance: clinical application of T regulatory cells.

Authors:  Alicia N McMurchy; Andrew Bushell; Megan K Levings; Kathryn J Wood
Journal:  Semin Immunol       Date:  2011-05-28       Impact factor: 11.130

9.  Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell.

Authors:  B M Hall
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

10.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells.

Authors:  B M Hall; M E Jelbart; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.